Molecular Reclassification to Find Clinically Useful Biomarkers for Systemic Autoimmune Diseases

Datos básicos

PROYECTO Ayuda de investigación EUROPEA Subvención 127.950,00 € EU13/01- PRECISESADS Año de incio: 2014 Año de finalización: 2019

Objetivos del proyecto

The PRECISESADs consortium concurs to this call as a translational network of outstanding clinical, translational and basic researchers and practicing physicians with the common aim to give this challenge a practical and clinically relevant answer.The PRECISESADS project studied over 2 000 people with various autoimmune diseases, gathering data on the molecular causes of their disease as well as their clinical symptoms. Using this information, they will identified potential new classifications of these diseases, something that could allow doctors to offer patients more personalised treatments at an earlier stage of their disease.